VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts
ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family is known to play an important role in the pathogenesis of osteoarthritis (OA), working on aggrecan degradation or altering the integrity of extracellular matrix (ECM). Thus, the main purpose of our study was to define the...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/23111 |
| Acceso en línea: | https://hdl.handle.net/20.500.14352/23111 |
| Access Level: | acceso abierto |
| Palabra clave: | 577.112 616.72-002 VIP CRF ADAMTS Osteoarthritis Synovial fibroblast COMP Glycosaminoglycans Reumatología Bioquímica (Biología) 3205.09 Reumatología 2302 Bioquímica |
| id |
ES_49ad043a1f17cc33e4374690ccff6c4e |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/23111 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblastsPérez García, SeleneCarrión Caballo, MarGutiérrez Cañas, IreneGonzález Álvaro, IsidoroPérez Gomáriz, Rosa MaríaJuarranz Moratilla, Yasmina577.112616.72-002VIPCRFADAMTSOsteoarthritisSynovial fibroblastCOMPGlycosaminoglycansReumatologíaBioquímica (Biología)3205.09 Reumatología2302 BioquímicaADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family is known to play an important role in the pathogenesis of osteoarthritis (OA), working on aggrecan degradation or altering the integrity of extracellular matrix (ECM). Thus, the main purpose of our study was to define the role of vasoactive intestinal peptide (VIP) and corticotrophin-releasing factor (CRF), as immunoregulatory neuropeptides, on ADAMTS production in synovial fibroblasts (SF) from OA patients and healthy donors (HD). OA- and HD-SF were stimulated with pro-inflammatory mediators and treated with VIP or CRF. Both neuropeptides decreased ADAMTS-4, -5, -7 and -12 expressions, aggrecanase activity,glycosaminoglycans (GAG), and cartilage oligomeric matrix protein (COMP) degradation after stimulation with fibronectin fragments (Fn-fs) in OA-SF. After stimulation with interleukin-1b, VIP reduced ADAMTS-4 and -5, and both neuropeptides decreased ADAMTS-7 production and COMP degradation. Moreover, VIP and CRF reduced Runx2 and b-catenin activation in OA-SF. Our data suggest that the role of VIP and CRF on ADAMTS expression and cartilage degradation could be related to the OA pathology since scarce effects were produced in HD-SF. In addition,their effects might be greater when a degradation loop has been established, given that they were higher after stimulation with Fn-fs. Our results point to novel OA therapies based on the use of neuropeptides, since VIP and CRF are able to stop the first critical step, the loss of cartilageaggrecan and the ECM destabilization during joint degradationJohn WilleyUniversidad Complutense de Madrid20162016-04-0120162016-04-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/23111reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/231112026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| title |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| spellingShingle |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts Pérez García, Selene 577.112 616.72-002 VIP CRF ADAMTS Osteoarthritis Synovial fibroblast COMP Glycosaminoglycans Reumatología Bioquímica (Biología) 3205.09 Reumatología 2302 Bioquímica |
| title_short |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| title_full |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| title_fullStr |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| title_full_unstemmed |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| title_sort |
VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts |
| dc.creator.none.fl_str_mv |
Pérez García, Selene Carrión Caballo, Mar Gutiérrez Cañas, Irene González Álvaro, Isidoro Pérez Gomáriz, Rosa María Juarranz Moratilla, Yasmina |
| author |
Pérez García, Selene |
| author_facet |
Pérez García, Selene Carrión Caballo, Mar Gutiérrez Cañas, Irene González Álvaro, Isidoro Pérez Gomáriz, Rosa María Juarranz Moratilla, Yasmina |
| author_role |
author |
| author2 |
Carrión Caballo, Mar Gutiérrez Cañas, Irene González Álvaro, Isidoro Pérez Gomáriz, Rosa María Juarranz Moratilla, Yasmina |
| author2_role |
author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
577.112 616.72-002 VIP CRF ADAMTS Osteoarthritis Synovial fibroblast COMP Glycosaminoglycans Reumatología Bioquímica (Biología) 3205.09 Reumatología 2302 Bioquímica |
| topic |
577.112 616.72-002 VIP CRF ADAMTS Osteoarthritis Synovial fibroblast COMP Glycosaminoglycans Reumatología Bioquímica (Biología) 3205.09 Reumatología 2302 Bioquímica |
| description |
ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family is known to play an important role in the pathogenesis of osteoarthritis (OA), working on aggrecan degradation or altering the integrity of extracellular matrix (ECM). Thus, the main purpose of our study was to define the role of vasoactive intestinal peptide (VIP) and corticotrophin-releasing factor (CRF), as immunoregulatory neuropeptides, on ADAMTS production in synovial fibroblasts (SF) from OA patients and healthy donors (HD). OA- and HD-SF were stimulated with pro-inflammatory mediators and treated with VIP or CRF. Both neuropeptides decreased ADAMTS-4, -5, -7 and -12 expressions, aggrecanase activity,glycosaminoglycans (GAG), and cartilage oligomeric matrix protein (COMP) degradation after stimulation with fibronectin fragments (Fn-fs) in OA-SF. After stimulation with interleukin-1b, VIP reduced ADAMTS-4 and -5, and both neuropeptides decreased ADAMTS-7 production and COMP degradation. Moreover, VIP and CRF reduced Runx2 and b-catenin activation in OA-SF. Our data suggest that the role of VIP and CRF on ADAMTS expression and cartilage degradation could be related to the OA pathology since scarce effects were produced in HD-SF. In addition,their effects might be greater when a degradation loop has been established, given that they were higher after stimulation with Fn-fs. Our results point to novel OA therapies based on the use of neuropeptides, since VIP and CRF are able to stop the first critical step, the loss of cartilageaggrecan and the ECM destabilization during joint degradation |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016 2016-04-01 2016 2016-04-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/23111 |
| url |
https://hdl.handle.net/20.500.14352/23111 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 3.0 España https://creativecommons.org/licenses/by/3.0/es/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 3.0 España https://creativecommons.org/licenses/by/3.0/es/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
John Willey |
| publisher.none.fl_str_mv |
John Willey |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407439048146944 |
| score |
15,300719 |